- Biotechnology company, AnPac Bio-Medical Science ( NASDAQ: ANPC ) a nnounced that in December 2022 and January 2023, the Company signed definitive investment agreements with several third party investors.
- The investors agreed to purchase ~29.71M newly issued shares (1.48M ADS) at a price of $0.175 per ordinary share or $3.50 per ADS (1:20 ADS-to-share ratio), for a total purchase price of $5.2M.
- The closing is expected to take place within 30 days after signing.
- The company expects to use the proceeds for its business-to-business Asian food e-commerce and Asian food supply chain construction.
For further details see:
AnPac Bio-Medical Science signs $5.2M investment agreements